Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’

Detalles Bibliográficos
Autor principal: Karlin-Neumann, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757476/
https://www.ncbi.nlm.nih.gov/pubmed/29345689
http://dx.doi.org/10.1136/esmoopen-2017-000287
_version_ 1783290864975478784
author Karlin-Neumann, George
author_facet Karlin-Neumann, George
author_sort Karlin-Neumann, George
collection PubMed
description
format Online
Article
Text
id pubmed-5757476
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57574762018-01-17 Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’ Karlin-Neumann, George ESMO Open Correspondence BMJ Publishing Group 2018-01-03 /pmc/articles/PMC5757476/ /pubmed/29345689 http://dx.doi.org/10.1136/esmoopen-2017-000287 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Correspondence
Karlin-Neumann, George
Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’
title Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’
title_full Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’
title_fullStr Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’
title_full_unstemmed Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’
title_short Concerns with conclusions in the article by Sherwood et al ‘Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice’
title_sort concerns with conclusions in the article by sherwood et al ‘key differences between 13 kras mutation detection technologies and their relevance for clinical practice’
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757476/
https://www.ncbi.nlm.nih.gov/pubmed/29345689
http://dx.doi.org/10.1136/esmoopen-2017-000287
work_keys_str_mv AT karlinneumanngeorge concernswithconclusionsinthearticlebysherwoodetalkeydifferencesbetween13krasmutationdetectiontechnologiesandtheirrelevanceforclinicalpractice

Ejemplares similares